Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients

Table 3 Multivariate analysis of the association between prognostic variables and overall survival in NSCLC

Variables	Hazard ratio (95% CI)	Se (Coef)	z	p value
pT stage	2.91 (1.77–4.78)	0.254	4.196	< 0.001
pN stage	2.02 (1.31–3.11)	0.221	3.171	0.002
M2 ratio^high	1.53 (1.01–2.33)	0.214	1.992	0.046
Dual M2 ratio^high & VEGF-C^high	2.01 (1.28–3.16)	0.231	3.028	0.003

M2 ratio, CD163+/CD68+
NSCLC non-small cell lung cancer, CI confidence interval, VEGF vascular endothelial growth factor

ISSN: 1479-5876